ARTICLE | Company News
FDA to review Sepracor's Soltara NDA
May 9, 2001 7:00 AM UTC
The FDA accepted for filing SEPR's NDA for its Soltara norastemizole third generation nonsedating antihistamine to treat allergic rhinitis. SEPR developed Soltara with Johnson & Johnson (JNJ), which i...